Sows and gilts are commonly vaccinated to protect their offspring against atrophic rhinitis (AR) caused by toxigenic strains of Bordetella bronchiseptica and Pasteurella multocida type D (PMT). RHINISENG® is a vaccine for the prevention of progressive and non-progressive AR in swine, indicated for pregnant sows and gilts; it contains HIPRAMUNE® Gd as an adjuvant based on ginsenosides. The aim of this study was to evaluate the duration of passive immunity against progressive AR in piglets of gilts vaccinated with RHINISENG®.
Duration of protective immunity against atrophic rhinitis in piglets after vaccination of gilts using RHINISENG® under field conditions
Publications
Swine
The study revealed that the immunization of gilts with three doses of RHINISENG® prior to the first farrowing induced a robust humoral response that resulted in a high and homogeneous concentration of colostral antibodies in piglets. The duration of passive immunity against PMT exceeded 70 days of age in all animals and it began to decrease towards 105 days of age in piglets from gilts vaccinated with RHINISENG®.
Download this article
Related products
The first intradermal needle-free vaccine against Mycoplasma hyopneumoniae and PCV2, all in one, in suspension for injection
Live vaccine against porcine reproductive and respiratory syndrome (PRRS), in injectable freeze-dried tablet
Purified recombinant verotoxin 2e against edema disease, in suspension for injection
Inactivated vaccine, against progressive and non progressive swine atrophic rhinitis, in injectable suspension.
Inactivated vaccine against neonatal colibacillosis and Clostridium infections in swine, in injectable suspension
Inactivated vaccine against Clostridioides difficile and Clostridium perfringens type A infections in swine, in injectable suspension.
Inactivated vaccine against porcine parvovirus and swine erysipelas, in injectable suspension
Inactivated vaccine against swine erysipelas, parvovirosis and leptospirosis, in injectable suspension
Live vaccine against Aujeszky’s disease gE negative strain, in injectable freeze-dried tablet
Inactivated vaccine against swine erysipelas, in injectable suspension
Inactivated porcine against porcine parvovirus, in injectable suspension
Inactivated vaccine against enzootic pneumonia, in injectable suspension
Related services
Smart Vaccination by HIPRA is a revolutionary concept that combines: A smart vaccine including RFID technology in its label, a vaccination device which ensures precision and efficiency, and a new world of digital solutions in HIPRAlink Vaccination. All these elements are developed internally by HIPRA.
In Swine, the HIPRA SMART VACCINATION is spearheaded by our innovative MHYOSPHERE® PCV ID and UNISTRAIN® PRRS vaccines, the needle-free intradermal device Hipradermic® and the professional veterinary app HIPRAlink® Vaccination.
An innovative service based on data analysis that facilitates decision-making in swine
HIPRA Stats is a data analysis service for animal production companies.
Hipradermic® is an advanced needle-free injection device with wireless connectivity for the intradermal vaccination of pigs.
HIPRA University offers high quality training programmes in strategic areas of interest for professionals
Access an advanced diagnostic service with maximum comfort and reliability
